Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonoscopy | 34 | 2024 | 1406 | 5.610 |
Why?
|
Cathartics | 15 | 2021 | 129 | 4.090 |
Why?
|
Gastroenterology | 13 | 2023 | 594 | 3.000 |
Why?
|
Endosonography | 15 | 2022 | 626 | 2.010 |
Why?
|
Endoscopy, Gastrointestinal | 25 | 2023 | 888 | 1.830 |
Why?
|
Barrett Esophagus | 12 | 2019 | 494 | 1.680 |
Why?
|
Colonic Polyps | 6 | 2017 | 556 | 1.170 |
Why?
|
Preoperative Care | 6 | 2020 | 2267 | 1.000 |
Why?
|
Gastroesophageal Reflux | 7 | 2017 | 833 | 0.970 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6942 | 0.840 |
Why?
|
Adenoma | 4 | 2015 | 2152 | 0.710 |
Why?
|
Gastrointestinal Hemorrhage | 10 | 2022 | 1127 | 0.700 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2023 | 616 | 0.670 |
Why?
|
Editorial Policies | 2 | 2021 | 458 | 0.660 |
Why?
|
Occult Blood | 1 | 2020 | 198 | 0.660 |
Why?
|
Esophagoscopy | 4 | 2019 | 398 | 0.660 |
Why?
|
Diet Therapy | 1 | 2019 | 149 | 0.610 |
Why?
|
Esophageal Achalasia | 1 | 2019 | 99 | 0.600 |
Why?
|
Intestinal Polyposis | 3 | 2022 | 42 | 0.580 |
Why?
|
Peutz-Jeghers Syndrome | 3 | 2022 | 61 | 0.580 |
Why?
|
Patient Education as Topic | 4 | 2017 | 2334 | 0.560 |
Why?
|
Hamartoma Syndrome, Multiple | 3 | 2022 | 116 | 0.540 |
Why?
|
Endoscopy, Digestive System | 4 | 2014 | 358 | 0.540 |
Why?
|
Quality Indicators, Health Care | 11 | 2013 | 1806 | 0.530 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 144 | 0.510 |
Why?
|
Colonic Diseases | 4 | 2010 | 204 | 0.510 |
Why?
|
Hamartoma | 3 | 2022 | 233 | 0.500 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 961 | 0.500 |
Why?
|
Stomach Neoplasms | 2 | 2022 | 1471 | 0.500 |
Why?
|
Digestive System Diseases | 3 | 2014 | 151 | 0.480 |
Why?
|
Societies, Medical | 5 | 2022 | 3956 | 0.480 |
Why?
|
Early Detection of Cancer | 8 | 2024 | 3236 | 0.460 |
Why?
|
Dietary Fiber | 1 | 2018 | 767 | 0.450 |
Why?
|
Internet | 3 | 2014 | 3106 | 0.420 |
Why?
|
Esophageal Neoplasms | 6 | 2019 | 1661 | 0.400 |
Why?
|
Quality Assurance, Health Care | 11 | 2018 | 2172 | 0.390 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1657 | 0.390 |
Why?
|
Quality Improvement | 3 | 2018 | 3853 | 0.380 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2659 | 0.380 |
Why?
|
Histamine H2 Antagonists | 3 | 2017 | 168 | 0.380 |
Why?
|
Proton Pump Inhibitors | 5 | 2017 | 553 | 0.370 |
Why?
|
Neoplastic Syndromes, Hereditary | 3 | 2022 | 248 | 0.370 |
Why?
|
Legislation, Medical | 1 | 2011 | 99 | 0.360 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1462 | 0.340 |
Why?
|
Precancerous Conditions | 3 | 2021 | 976 | 0.340 |
Why?
|
Humans | 126 | 2024 | 765956 | 0.340 |
Why?
|
Congresses as Topic | 2 | 2014 | 811 | 0.330 |
Why?
|
Biostatistics | 1 | 2011 | 162 | 0.320 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2003 | 0.320 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 9 | 2010 | 520 | 0.320 |
Why?
|
Antacids | 1 | 2008 | 94 | 0.300 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2008 | 134 | 0.290 |
Why?
|
Gastrointestinal Tract | 2 | 2023 | 834 | 0.280 |
Why?
|
Biopsy, Needle | 5 | 2008 | 1628 | 0.280 |
Why?
|
Publishing | 1 | 2014 | 835 | 0.270 |
Why?
|
Biopsy, Fine-Needle | 5 | 2006 | 1133 | 0.270 |
Why?
|
Overweight | 2 | 2009 | 2443 | 0.260 |
Why?
|
Mass Screening | 7 | 2024 | 5445 | 0.260 |
Why?
|
Heartburn | 1 | 2006 | 71 | 0.260 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2007 | 174 | 0.250 |
Why?
|
Esophagitis | 2 | 2006 | 163 | 0.250 |
Why?
|
Nutritional Support | 1 | 2007 | 178 | 0.250 |
Why?
|
DNA | 1 | 2019 | 7202 | 0.250 |
Why?
|
Esophageal Stenosis | 1 | 2007 | 196 | 0.250 |
Why?
|
Diet | 4 | 2018 | 8086 | 0.240 |
Why?
|
Pharmaceutical Preparations | 1 | 2013 | 1084 | 0.230 |
Why?
|
Diet, Fat-Restricted | 1 | 2007 | 328 | 0.230 |
Why?
|
Body Mass Index | 6 | 2011 | 13039 | 0.230 |
Why?
|
Politics | 1 | 2011 | 822 | 0.230 |
Why?
|
International Classification of Diseases | 2 | 2022 | 935 | 0.220 |
Why?
|
Environmental Exposure | 1 | 2019 | 4543 | 0.220 |
Why?
|
Gastroscopy | 3 | 2006 | 213 | 0.220 |
Why?
|
Catheterization | 3 | 2007 | 1425 | 0.210 |
Why?
|
Middle Aged | 33 | 2021 | 223004 | 0.200 |
Why?
|
Pancreatic Diseases | 1 | 2005 | 353 | 0.200 |
Why?
|
Mediastinum | 1 | 2003 | 271 | 0.200 |
Why?
|
Interferometry | 1 | 2002 | 101 | 0.190 |
Why?
|
Lymphatic Diseases | 1 | 2003 | 317 | 0.190 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1206 | 0.190 |
Why?
|
Urinary Bladder Fistula | 1 | 2001 | 10 | 0.190 |
Why?
|
Endoscopy | 2 | 2011 | 1841 | 0.190 |
Why?
|
Pancreatitis | 4 | 2005 | 1087 | 0.190 |
Why?
|
Estrogens | 1 | 2008 | 1529 | 0.190 |
Why?
|
Biomedical Research | 2 | 2014 | 3458 | 0.180 |
Why?
|
Gallbladder Neoplasms | 1 | 2003 | 189 | 0.180 |
Why?
|
Sigmoid Neoplasms | 1 | 2001 | 54 | 0.180 |
Why?
|
Prospective Studies | 14 | 2019 | 54806 | 0.180 |
Why?
|
Odds Ratio | 5 | 2015 | 9649 | 0.180 |
Why?
|
Pancreatic Cyst | 1 | 2005 | 373 | 0.180 |
Why?
|
Peritonitis | 2 | 2005 | 369 | 0.180 |
Why?
|
Intestinal Fistula | 1 | 2001 | 146 | 0.170 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2531 | 0.170 |
Why?
|
Female | 42 | 2021 | 396101 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2002 | 443 | 0.170 |
Why?
|
Laxatives | 1 | 2020 | 94 | 0.170 |
Why?
|
Stomach Diseases | 2 | 2003 | 134 | 0.170 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12807 | 0.170 |
Why?
|
Tomography | 1 | 2002 | 443 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16047 | 0.160 |
Why?
|
Esophageal Sphincter, Lower | 1 | 2019 | 26 | 0.160 |
Why?
|
Lymphatic Metastasis | 1 | 2007 | 2887 | 0.160 |
Why?
|
Dietary Fats | 1 | 2007 | 2002 | 0.160 |
Why?
|
Gallstones | 1 | 2002 | 285 | 0.160 |
Why?
|
Herpesviridae Infections | 1 | 2000 | 268 | 0.150 |
Why?
|
Algorithms | 1 | 2019 | 14071 | 0.150 |
Why?
|
Needles | 1 | 2002 | 460 | 0.150 |
Why?
|
Neoplasm Staging | 6 | 2019 | 11206 | 0.150 |
Why?
|
Poultry | 1 | 2018 | 79 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2022 | 596 | 0.150 |
Why?
|
Intestinal Polyps | 3 | 2022 | 105 | 0.140 |
Why?
|
Helicobacter pylori | 1 | 2001 | 380 | 0.140 |
Why?
|
Dilatation | 1 | 2019 | 310 | 0.140 |
Why?
|
Helicobacter Infections | 1 | 2001 | 390 | 0.140 |
Why?
|
Male | 31 | 2021 | 363691 | 0.140 |
Why?
|
Aged | 21 | 2021 | 171114 | 0.140 |
Why?
|
Incidence | 9 | 2022 | 21480 | 0.140 |
Why?
|
Clinical Competence | 2 | 2012 | 4863 | 0.140 |
Why?
|
Telephone | 1 | 2001 | 627 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18071 | 0.140 |
Why?
|
Birth Injuries | 1 | 1998 | 150 | 0.140 |
Why?
|
Risk Assessment | 7 | 2022 | 24283 | 0.130 |
Why?
|
Gelatin | 1 | 2018 | 227 | 0.130 |
Why?
|
Lymphoproliferative Disorders | 1 | 2000 | 526 | 0.130 |
Why?
|
Waist-Hip Ratio | 2 | 2009 | 520 | 0.130 |
Why?
|
Neurilemmoma | 1 | 2001 | 522 | 0.130 |
Why?
|
Weight Gain | 1 | 2006 | 2355 | 0.130 |
Why?
|
Lymph Nodes | 1 | 2007 | 3454 | 0.130 |
Why?
|
Risk Factors | 15 | 2024 | 74836 | 0.120 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1292 | 0.120 |
Why?
|
Smoking | 2 | 2012 | 9081 | 0.120 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1188 | 0.120 |
Why?
|
United States | 14 | 2023 | 72898 | 0.120 |
Why?
|
Herpesvirus 4, Human | 1 | 2000 | 1078 | 0.110 |
Why?
|
Confidence Intervals | 2 | 2012 | 2910 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2009 | 4300 | 0.110 |
Why?
|
Esophageal Diseases | 1 | 2014 | 166 | 0.110 |
Why?
|
Adenocarcinoma | 4 | 2021 | 6364 | 0.110 |
Why?
|
Acute Disease | 3 | 2019 | 7232 | 0.100 |
Why?
|
Obesity | 3 | 2011 | 13075 | 0.100 |
Why?
|
Vegetables | 1 | 2018 | 1200 | 0.100 |
Why?
|
Observer Variation | 3 | 2021 | 2615 | 0.100 |
Why?
|
Violence | 1 | 1998 | 935 | 0.100 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2022 | 1188 | 0.100 |
Why?
|
Peer Review | 1 | 2014 | 217 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2000 | 2729 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2001 | 1135 | 0.100 |
Why?
|
Sex Distribution | 2 | 2008 | 2263 | 0.100 |
Why?
|
Delivery, Obstetric | 1 | 1998 | 946 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 368 | 0.090 |
Why?
|
Age Distribution | 2 | 2008 | 2858 | 0.090 |
Why?
|
Adult | 18 | 2024 | 223038 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2021 | 59488 | 0.090 |
Why?
|
Histamine | 1 | 1992 | 497 | 0.090 |
Why?
|
Colon | 2 | 2017 | 1795 | 0.090 |
Why?
|
Thrombin | 1 | 1992 | 602 | 0.080 |
Why?
|
Hearing Loss | 1 | 2017 | 784 | 0.080 |
Why?
|
Stents | 3 | 2010 | 3213 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20125 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 830 | 0.080 |
Why?
|
Logistic Models | 3 | 2015 | 13266 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39194 | 0.080 |
Why?
|
Video Recording | 1 | 2014 | 969 | 0.080 |
Why?
|
Biliary Tract Neoplasms | 1 | 2010 | 186 | 0.080 |
Why?
|
Administration, Oral | 2 | 2020 | 4015 | 0.080 |
Why?
|
Conscious Sedation | 2 | 2003 | 531 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2019 | 22222 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 326 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6897 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2002 | 2429 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2022 | 12437 | 0.070 |
Why?
|
Suicide | 1 | 1998 | 1604 | 0.070 |
Why?
|
Cholestasis | 1 | 2010 | 386 | 0.070 |
Why?
|
Nonprescription Drugs | 1 | 2008 | 119 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2020 | 65189 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2008 | 11022 | 0.070 |
Why?
|
Public Policy | 1 | 2011 | 551 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2010 | 1588 | 0.070 |
Why?
|
Gastrointestinal Diseases | 3 | 2006 | 1203 | 0.070 |
Why?
|
Time Factors | 3 | 2018 | 40065 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2003 | 4900 | 0.070 |
Why?
|
Droperidol | 2 | 2003 | 21 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 7425 | 0.070 |
Why?
|
Endothelium, Vascular | 3 | 1995 | 4427 | 0.070 |
Why?
|
Duodenoscopy | 1 | 2006 | 45 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14652 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2014 | 1050 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 26313 | 0.060 |
Why?
|
Age Factors | 3 | 2022 | 18380 | 0.060 |
Why?
|
Educational Status | 1 | 2013 | 2513 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 5389 | 0.060 |
Why?
|
Elasticity | 1 | 2007 | 652 | 0.060 |
Why?
|
Protein Kinases | 1 | 1992 | 1611 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 933 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2019 | 81515 | 0.060 |
Why?
|
Duodenoscopes | 1 | 2005 | 43 | 0.060 |
Why?
|
Choledocholithiasis | 1 | 2005 | 50 | 0.060 |
Why?
|
Credentialing | 1 | 2005 | 118 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 13024 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1672 | 0.060 |
Why?
|
Probability | 2 | 2008 | 2475 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2007 | 15880 | 0.060 |
Why?
|
Sigmoidoscopy | 2 | 2003 | 150 | 0.060 |
Why?
|
Lithotripsy | 1 | 2005 | 136 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9338 | 0.050 |
Why?
|
Stomach Ulcer | 1 | 2003 | 118 | 0.050 |
Why?
|
Research Design | 1 | 2019 | 6208 | 0.050 |
Why?
|
Immunotherapy | 1 | 1999 | 4752 | 0.050 |
Why?
|
Hip Fractures | 1 | 2012 | 997 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2004 | 13451 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2005 | 345 | 0.050 |
Why?
|
Watchful Waiting | 2 | 2019 | 493 | 0.050 |
Why?
|
Postmenopause | 1 | 2012 | 2515 | 0.050 |
Why?
|
Electrocoagulation | 1 | 2003 | 157 | 0.050 |
Why?
|
Adjuvants, Anesthesia | 1 | 2002 | 59 | 0.050 |
Why?
|
Thinness | 1 | 2006 | 482 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1534 | 0.050 |
Why?
|
Lactation | 1 | 2005 | 391 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1992 | 2880 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2003 | 139 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2006 | 1072 | 0.050 |
Why?
|
Photomicrography | 1 | 2001 | 72 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3432 | 0.050 |
Why?
|
Sampling Studies | 1 | 2003 | 607 | 0.050 |
Why?
|
Antibiotic Prophylaxis | 2 | 2003 | 644 | 0.050 |
Why?
|
Palliative Care | 2 | 2010 | 3645 | 0.050 |
Why?
|
Cautery | 1 | 2001 | 73 | 0.050 |
Why?
|
Bile | 1 | 2002 | 300 | 0.040 |
Why?
|
NADP | 1 | 2002 | 229 | 0.040 |
Why?
|
Omeprazole | 1 | 2001 | 106 | 0.040 |
Why?
|
Gastric Outlet Obstruction | 1 | 2001 | 55 | 0.040 |
Why?
|
Crystallization | 1 | 2002 | 521 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2012 | 3564 | 0.040 |
Why?
|
Anti-Ulcer Agents | 1 | 2001 | 112 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2003 | 407 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2011 | 2243 | 0.040 |
Why?
|
Constipation | 1 | 2005 | 568 | 0.040 |
Why?
|
Duodenal Diseases | 1 | 2001 | 101 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10729 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.040 |
Why?
|
Gallbladder | 1 | 2002 | 308 | 0.040 |
Why?
|
Life Style | 1 | 2012 | 3926 | 0.040 |
Why?
|
Solutions | 1 | 2020 | 403 | 0.040 |
Why?
|
Intestines | 1 | 2009 | 1906 | 0.040 |
Why?
|
Calcium | 3 | 1995 | 5767 | 0.040 |
Why?
|
Lactones | 1 | 2002 | 316 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2002 | 397 | 0.040 |
Why?
|
von Willebrand Factor | 2 | 1995 | 676 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2006 | 12057 | 0.040 |
Why?
|
Taste | 1 | 2020 | 190 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6203 | 0.040 |
Why?
|
Light | 2 | 2002 | 1364 | 0.040 |
Why?
|
Policy | 1 | 2023 | 511 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2003 | 1792 | 0.040 |
Why?
|
Esophagus | 2 | 2002 | 1037 | 0.040 |
Why?
|
Oxygen Consumption | 4 | 1986 | 1870 | 0.040 |
Why?
|
Cholangiocarcinoma | 1 | 2003 | 578 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2006 | 1892 | 0.040 |
Why?
|
Proteins | 1 | 1992 | 5995 | 0.040 |
Why?
|
Opportunistic Infections | 1 | 2000 | 376 | 0.030 |
Why?
|
Intestinal Obstruction | 1 | 2001 | 432 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 2000 | 602 | 0.030 |
Why?
|
Neoplasms | 1 | 2006 | 22340 | 0.030 |
Why?
|
Photochemotherapy | 1 | 2003 | 826 | 0.030 |
Why?
|
Drug Utilization | 1 | 2003 | 1187 | 0.030 |
Why?
|
Propofol | 1 | 2002 | 606 | 0.030 |
Why?
|
Leukotriene D4 | 1 | 1995 | 33 | 0.030 |
Why?
|
Colectomy | 1 | 2001 | 697 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1182 | 0.030 |
Why?
|
Sweden | 1 | 1998 | 1381 | 0.030 |
Why?
|
Leukotriene C4 | 1 | 1995 | 79 | 0.030 |
Why?
|
Membrane Proteins | 1 | 1992 | 7851 | 0.030 |
Why?
|
Cohort Studies | 4 | 2010 | 41647 | 0.030 |
Why?
|
Gastric Bypass | 1 | 2003 | 820 | 0.030 |
Why?
|
Prognosis | 3 | 2006 | 29921 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2001 | 1472 | 0.030 |
Why?
|
Hospital Administration | 1 | 2018 | 352 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 4058 | 0.030 |
Why?
|
Paris | 1 | 2014 | 40 | 0.030 |
Why?
|
Overnutrition | 1 | 2014 | 25 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2003 | 5444 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 1989 | 10261 | 0.030 |
Why?
|
Collagen | 1 | 2002 | 2618 | 0.030 |
Why?
|
Length of Stay | 1 | 2007 | 6485 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1965 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2018 | 568 | 0.030 |
Why?
|
P-Selectin | 1 | 1995 | 597 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2005 | 2770 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4850 | 0.030 |
Why?
|
Cholesterol | 1 | 2002 | 2898 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.030 |
Why?
|
Animals | 10 | 2018 | 168759 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15398 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1315 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
Precipitin Tests | 1 | 1992 | 812 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2268 | 0.020 |
Why?
|
Comorbidity | 1 | 2006 | 10563 | 0.020 |
Why?
|
Micronutrients | 1 | 2014 | 390 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2002 | 3046 | 0.020 |
Why?
|
Prevalence | 3 | 2014 | 15839 | 0.020 |
Why?
|
Prenatal Care | 1 | 1998 | 1159 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2005 | 2971 | 0.020 |
Why?
|
Equipment Design | 2 | 2010 | 3481 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2163 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1724 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1275 | 0.020 |
Why?
|
Aging | 1 | 1989 | 8731 | 0.020 |
Why?
|
Aspirin | 1 | 2001 | 3134 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2387 | 0.020 |
Why?
|
Adipokines | 1 | 2011 | 308 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 2 | 2002 | 697 | 0.020 |
Why?
|
Ionomycin | 1 | 1989 | 109 | 0.020 |
Why?
|
Ethers | 1 | 1989 | 73 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2000 | 1646 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5876 | 0.020 |
Why?
|
Pilot Projects | 1 | 2002 | 8733 | 0.020 |
Why?
|
Biopsy | 1 | 2000 | 6763 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 1991 | 574 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3475 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20660 | 0.020 |
Why?
|
Calmodulin | 1 | 1989 | 240 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12976 | 0.020 |
Why?
|
Bacteremia | 2 | 2005 | 989 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 1988 | 276 | 0.020 |
Why?
|
Chronic Disease | 1 | 2002 | 9347 | 0.020 |
Why?
|
Pneumonia | 1 | 2018 | 2157 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1992 | 3586 | 0.020 |
Why?
|
Dithioerythritol | 1 | 1986 | 8 | 0.020 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1986 | 23 | 0.020 |
Why?
|
Dithiothreitol | 1 | 1986 | 92 | 0.020 |
Why?
|
Calcium Channel Blockers | 2 | 1988 | 686 | 0.020 |
Why?
|
Selenium | 1 | 1989 | 419 | 0.020 |
Why?
|
Metals | 1 | 2010 | 710 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1998 | 2531 | 0.020 |
Why?
|
Sarcoma, Experimental | 1 | 1986 | 116 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2119 | 0.020 |
Why?
|
Biliary Tract Diseases | 1 | 2006 | 160 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9591 | 0.020 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 1989 | 329 | 0.020 |
Why?
|
Celiac Plexus | 1 | 2005 | 34 | 0.010 |
Why?
|
Sex Factors | 1 | 1998 | 10602 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 1989 | 871 | 0.010 |
Why?
|
Autonomic Nerve Block | 1 | 2005 | 84 | 0.010 |
Why?
|
Protein Kinase C | 1 | 1989 | 1202 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5369 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 59886 | 0.010 |
Why?
|
Fibrosarcoma | 1 | 1986 | 313 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1988 | 1467 | 0.010 |
Why?
|
Phosphorylation | 2 | 1992 | 8278 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 2005 | 284 | 0.010 |
Why?
|
Tranquilizing Agents | 1 | 2003 | 59 | 0.010 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2003 | 44 | 0.010 |
Why?
|
Pain | 1 | 2018 | 5077 | 0.010 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2003 | 121 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 1986 | 498 | 0.010 |
Why?
|
Ampulla of Vater | 1 | 2003 | 150 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1992 | 2817 | 0.010 |
Why?
|
Barium Sulfate | 1 | 2003 | 180 | 0.010 |
Why?
|
Enema | 1 | 2003 | 140 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 10383 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 88832 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2018 | 15747 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2014 | 3211 | 0.010 |
Why?
|
Nurses | 1 | 2012 | 2505 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1995 | 18973 | 0.010 |
Why?
|
Body Composition | 1 | 2011 | 2439 | 0.010 |
Why?
|
Joint Prosthesis | 1 | 2003 | 233 | 0.010 |
Why?
|
Neoplasms, Experimental | 2 | 1984 | 1229 | 0.010 |
Why?
|
Pregnancy | 2 | 2005 | 30258 | 0.010 |
Why?
|
Narcotics | 1 | 2003 | 332 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2005 | 413 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 2003 | 402 | 0.010 |
Why?
|
Pharynx | 1 | 2003 | 436 | 0.010 |
Why?
|
Constriction, Pathologic | 2 | 2003 | 1105 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3925 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6832 | 0.010 |
Why?
|
Pressure | 1 | 1963 | 1168 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2001 | 482 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2002 | 647 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2003 | 434 | 0.010 |
Why?
|
Sulfones | 1 | 2002 | 447 | 0.010 |
Why?
|
Stomach | 1 | 1963 | 699 | 0.010 |
Why?
|
Postoperative Period | 1 | 2003 | 1816 | 0.010 |
Why?
|
Narcotic Antagonists | 1 | 2003 | 590 | 0.010 |
Why?
|
Blood Vessel Prosthesis | 1 | 2003 | 912 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1989 | 5881 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 866 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8501 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 392 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2002 | 579 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2003 | 1136 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2003 | 1069 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12509 | 0.010 |
Why?
|
Surgery, Computer-Assisted | 1 | 2005 | 993 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2003 | 1015 | 0.010 |
Why?
|
Anesthesia, General | 1 | 2003 | 1172 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21056 | 0.010 |
Why?
|
Hypnotics and Sedatives | 1 | 2003 | 1191 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1995 | 421 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6547 | 0.010 |
Why?
|
Kinetics | 3 | 1988 | 6274 | 0.010 |
Why?
|
Research | 1 | 1963 | 1975 | 0.010 |
Why?
|
Exocytosis | 1 | 1995 | 323 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13631 | 0.010 |
Why?
|
Motivation | 1 | 2003 | 2018 | 0.010 |
Why?
|
Succinates | 2 | 1984 | 82 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 1959 | 0.010 |
Why?
|
Radiography | 1 | 2003 | 6919 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2423 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2867 | 0.010 |
Why?
|
Mice | 6 | 1989 | 81818 | 0.010 |
Why?
|
Hemorrhage | 1 | 2003 | 3461 | 0.010 |
Why?
|
Patient Selection | 1 | 2003 | 4255 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2002 | 3681 | 0.010 |
Why?
|
Cricetinae | 2 | 1984 | 2411 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1989 | 80 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 8041 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1995 | 3807 | 0.000 |
Why?
|
2-Chloroadenosine | 1 | 1988 | 11 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10070 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1988 | 166 | 0.000 |
Why?
|
Glutathione Peroxidase | 1 | 1989 | 256 | 0.000 |
Why?
|
Hydrolysis | 1 | 1988 | 642 | 0.000 |
Why?
|
Cytochrome c Group | 1 | 1986 | 123 | 0.000 |
Why?
|
Nifedipine | 1 | 1986 | 220 | 0.000 |
Why?
|
Diltiazem | 1 | 1986 | 132 | 0.000 |
Why?
|
Cholera Toxin | 1 | 1988 | 563 | 0.000 |
Why?
|
Verapamil | 1 | 1986 | 242 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1988 | 1770 | 0.000 |
Why?
|
Electron Transport | 1 | 1986 | 210 | 0.000 |
Why?
|
Dinoprostone | 1 | 1988 | 591 | 0.000 |
Why?
|
Mice, Inbred C3H | 1 | 1986 | 914 | 0.000 |
Why?
|
Ethylmaleimide | 1 | 1984 | 69 | 0.000 |
Why?
|
Disulfides | 1 | 1986 | 462 | 0.000 |
Why?
|
Cell Communication | 1 | 1991 | 1660 | 0.000 |
Why?
|
Potassium Cyanide | 1 | 1983 | 17 | 0.000 |
Why?
|
Succinic Acid | 1 | 1984 | 86 | 0.000 |
Why?
|
Adenosine | 1 | 1988 | 806 | 0.000 |
Why?
|
Rotenone | 1 | 1983 | 50 | 0.000 |
Why?
|
Glutamates | 1 | 1984 | 384 | 0.000 |
Why?
|
Glucose | 2 | 1986 | 4335 | 0.000 |
Why?
|
Reference Values | 1 | 1989 | 4908 | 0.000 |
Why?
|
Cell Line | 2 | 1986 | 15543 | 0.000 |
Why?
|
Cricetulus | 1 | 1983 | 805 | 0.000 |
Why?
|
Blood Platelets | 1 | 1991 | 2464 | 0.000 |
Why?
|
Glutamine | 1 | 1983 | 576 | 0.000 |
Why?
|
Homeostasis | 1 | 1991 | 3336 | 0.000 |
Why?
|
Regression Analysis | 1 | 1989 | 6321 | 0.000 |
Why?
|
Dogs | 1 | 1963 | 3822 | 0.000 |
Why?
|
Ductus Arteriosus | 1 | 1958 | 42 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1984 | 1180 | 0.000 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1958 | 214 | 0.000 |
Why?
|
Models, Biological | 1 | 1991 | 9443 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1958 | 1030 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1989 | 26349 | 0.000 |
Why?
|
Aortic Valve | 1 | 1958 | 1968 | 0.000 |
Why?
|
Rats | 1 | 1984 | 23707 | 0.000 |
Why?
|
Aortic Valve Stenosis | 1 | 1958 | 2023 | 0.000 |
Why?
|
Lung | 1 | 1983 | 10033 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 1958 | 4698 | 0.000 |
Why?
|